Phase I study of the 177Lu-DOTA0-Tyr3-Octreotate (lutathera) in combination with nivolumab in patients with neuroendocrine tumors of the lung.
Chul KimStephen V LiuDeepa S SubramaniamTisdrey TorresMassimo LodaGiuseppe EspositoGiuseppe GiacconePublished in: Journal for immunotherapy of cancer (2021)
NCT03325816.
Keyphrases